Medistim ASA (OSL:MEDI)
220.00
-10.00 (-4.35%)
Jul 21, 2025, 4:25 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Third Party Products | 89.82M | Log In | Log In | Log In | Log In | Upgrade |
Third Party Products Growth | 22.19% | Log In | Log In | Log In | Log In | Upgrade |
Other | -6.43M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) | 61.34M | Log In | Log In | Log In | Log In | Upgrade |
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) Growth | -5.44% | Log In | Log In | Log In | Log In | Upgrade |
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) | 39.50M | Log In | Log In | Log In | Log In | Upgrade |
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) Growth | 13.80% | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Flow Systems | 55.22M | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Flow Systems Growth | 1.85% | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Flow and Imaging Systems | 69.17M | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Flow and Imaging Systems Growth | 19.11% | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Flow Probes | 231.47M | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Flow Probes Growth | 20.49% | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Imaging Probes | 16.08M | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Imaging Probes Growth | 18.57% | Log In | Log In | Log In | Log In | Upgrade |
Coronary Surgery | 379.05M | Log In | Log In | Log In | Log In | Upgrade |
Coronary Surgery Growth | 11.46% | Log In | Log In | Log In | Log In | Upgrade |
Vascular Surgery | 93.72M | Log In | Log In | Log In | Log In | Upgrade |
Vascular Surgery Growth | 23.32% | Log In | Log In | Log In | Log In | Upgrade |
Other Product | - | Log In | Log In | Log In | Log In | Upgrade |
Third Party Products | 89.82M | Log In | Log In | Log In | Log In | Upgrade |
Third Party Products Growth | 22.19% | Log In | Log In | Log In | Log In | Upgrade |
Other | -6.43M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Third Party Products | 89.82M | Log In | Log In | Log In | Log In | Upgrade |
Third Party Products Growth | 22.19% | Log In | Log In | Log In | Log In | Upgrade |
Other | 466.34M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 13.56% | Log In | Log In | Log In | Log In | Upgrade |
Third Party Products | 89.82M | Log In | Log In | Log In | Log In | Upgrade |
Third Party Products Growth | 22.19% | Log In | Log In | Log In | Log In | Upgrade |
Americas | 237.16M | Log In | Log In | Log In | Log In | Upgrade |
Americas Growth | 23.24% | Log In | Log In | Log In | Log In | Upgrade |
APAC | 65.46M | Log In | Log In | Log In | Log In | Upgrade |
APAC Growth | 0.61% | Log In | Log In | Log In | Log In | Upgrade |
EMEA | 170.16M | Log In | Log In | Log In | Log In | Upgrade |
EMEA Growth | 7.63% | Log In | Log In | Log In | Log In | Upgrade |
Other | 466.34M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 13.56% | Log In | Log In | Log In | Log In | Upgrade |
USA | - | Log In | Log In | Log In | Log In | Upgrade |
USA Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Asia | - | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Europe | - | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Rest Of The World | - | Log In | Log In | Log In | Log In | Upgrade |
Rest Of The World Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) Units Sold | 23.54K | Log In | Log In | Log In | Log In | Upgrade |
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) Units Sold Growth | -7.83% | Log In | Log In | Log In | Log In | Upgrade |
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) Units Sold | 7.48K | Log In | Log In | Log In | Log In | Upgrade |
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) Units Sold Growth | -1.65% | Log In | Log In | Log In | Log In | Upgrade |
PPP and Lease Revenue - Flow Systems (PPP/Lease) Units Sold | 4.00 | Log In | Log In | Log In | Log In | Upgrade |
PPP and Lease Revenue - Flow and Imaging Systems (PPP/Lease) Units Sold | 5.00 | Log In | Log In | Log In | Log In | Upgrade |
PPP and Lease Revenue - Flow and Imaging Systems (PPP/Lease) Units Sold Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Flow Systems Units Sold | 116.00 | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Flow Systems Units Sold Growth | 25.00% | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Flow and Imaging Systems Units Sold | 66.00 | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Flow and Imaging Systems Units Sold Growth | 73.33% | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Flow Probes Units Sold | 9.63K | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Flow Probes Units Sold Growth | 18.55% | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Imaging Probes Units Sold | 132.00 | Log In | Log In | Log In | Log In | Upgrade |
Capital Sales - Imaging Probes Units Sold Growth | 50.00% | Log In | Log In | Log In | Log In | Upgrade |